INCPF Analyst Ratings
Strong Buy
4 Buy
0 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
INCPF Stock 12 Month Forecast
Average Price Target
$2.53
▲(62.99% Upside)
| Highest Price Target$2.80 | Average Price Target$2.53 | Lowest Price Target$2.17 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Morgan Stanley
$2.17
Buy
39.80%
Upside
Reiterated
08/25/26
CMB International Securities
$1.52→$2.33
Buy
50.57%
Upside
Reiterated
04/24/26
Unknown Analyst
Guoyuan Securities (HK)Not Ranked
Guoyuan Securities (HK)
$2.14
Buy
38.24%
Upside
Reiterated
12/24/25
Goldman Sachs
$2.62→$2.92
Buy
88.24%
Upside
Reiterated
10/09/25
Analyst Type
Any
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Morgan Stanley
$2.17
Buy
39.80%
Upside
Reiterated
08/25/26
CMB International Securities
$1.52→$2.33
Buy
50.57%
Upside
Reiterated
04/24/26
Unknown Analyst
Guoyuan Securities (HK)Not Ranked
Guoyuan Securities (HK)
$2.14
Buy
38.24%
Upside
Reiterated
12/24/25
Goldman Sachs
$2.62→$2.92
Buy
88.24%
Upside
Reiterated
10/09/25
Best Analysts Covering InnoCare Pharma Ltd.
3 Months
1 Year
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
INCPF Analyst Recommendation Trends
Rating
May 26
Jun 26
Jul 26
Aug 26
Sep 26
Strong Buy
3
2
1
0
0
Buy
2
2
2
4
4
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
5
4
3
4
4
Each month's total comprises the sum of three months' worth of ratings.
INCPF Financial Forecast
INCPF Stock Forecast FAQ
What is INCPF’s average 12-month price target, according to analysts?
Based on analyst ratings, InnoCare Pharma Ltd.’s 12-month average price target is 2.53.
What is INCPF’s upside potential, based on the analysts’ average price target?
InnoCare Pharma Ltd. has 62.99% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is INCPF a Buy, Sell or Hold?
InnoCare Pharma Ltd. has a consensus rating of Strong Buy which is based on 4 buy ratings, 0 hold ratings and 0 sell ratings.
What is InnoCare Pharma Ltd.’s price target?
The average price target for InnoCare Pharma Ltd. is 2.53. This is based on 4 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $2.80 ,the lowest forecast is $2.17. The average price target represents 62.99% Increase from the current price of $1.55.
The highest analyst price target is $2.80 ,the lowest forecast is $2.17. The average price target represents 62.99% Increase from the current price of $1.55.
What do analysts say about InnoCare Pharma Ltd.?
InnoCare Pharma Ltd.’s analyst rating consensus is a Strong Buy. This is based on the ratings of 4 Wall Streets Analysts.
How can I buy shares of INCPF?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.